000			01976 a2200529 4500
005			20250517055440.0
264		0	_c20160427
008			201604s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2015.09.018 _2doi
040			_aNLM _beng _cNLM
100	1		_aHsieh, Hsiao-Yen
245	0	0	_aCyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways. _h[electronic resource]
260			_bCancer letters _cJan 2016
300			_a56-65 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiopoietin-Like Protein 4
650	0	4	_aAngiopoietins _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCyproheptadine _xpharmacology
650	0	4	_aG1 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors
650	0	4	_aGlycogen Synthase Kinase 3 beta
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aReceptors, Serotonin _xanalysis
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTuberous Sclerosis Complex 2 Protein
650	0	4	_aTumor Suppressor Proteins _xphysiology
650	0	4	_aUrinary Bladder Neoplasms _xdrug therapy
650	0	4	_abeta Catenin _xantagonists & inhibitors
700	1		_aShen, Cheng-Huang
700	1		_aLin, Ru-Inn
700	1		_aFeng, Yu-Min
700	1		_aHuang, Shih-Yuan
700	1		_aWang, Yuan-Hung
700	1		_aWu, Shu-Fen
700	1		_aHsu, Cheng-Da
700	1		_aChan, Michael W Y
773	0		_tCancer letters _gvol. 370 _gno. 1 _gp. 56-65
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2015.09.018 _zAvailable from publisher's website
999			_c25341710 _d25341710